Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 10.90
-0.15 (-1.36%)
Nov 14, 2025, 10:09 AM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 554.72 million as of November 13, 2025. Its market cap has decreased by -19.11% in one year.
Market Cap
554.72M
Enterprise Value
331.14M
Revenue
95.02M
Ranking
n/a
PE Ratio
15.39
Stock Price
10.90
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 554.72M, an increase of 10,515.26%. That is a compound annual growth rate of 20.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 554.72M | -7.91% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | 1.10B | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.55B |
| Pro Medicus | 26.88B |
| Cochlear | 18.75B |
| Sonic Healthcare | 10.41B |
| Ramsay Health Care | 7.08B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.22B |
| Mesoblast | 2.96B |